Hyperglycemia Aggravates the Cerebral Ischemia Injury via Protein O-GlcNAcylation

Jing Zhu1,2, Xin Ji3,2, Ruirui Shi2

  • 1Department of Rehabilitation Medicine, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, China.

Insights

Protein O-GlcNAcylation worsens ischemic stroke injury in hyperglycemia, contrary to its protective effects in normal conditions. Blocking this modification alleviates injury, suggesting it as a therapeutic target for stroke in diabetic patients.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Alzheimer's disease (AD) patients frequently exhibit cerebrovascular issues, increasing stroke risk.
  • Hyperglycemia exacerbates vascular damage and cerebral ischemia, posing a significant threat.
  • Protein O-GlcNAcylation is known to protect against ischemic stroke, but its role in hyperglycemia-induced exacerbation is unclear.

Purpose of the Study:

  • To investigate the mechanism by which protein O-GlcNAcylation exacerbates cerebral ischemia injury under hyperglycemic conditions.
  • To explore the therapeutic potential of targeting protein O-GlcNAcylation in hyperglycemia-related ischemic stroke.

Main Methods:

  • Utilized high glucose-cultured brain microvascular endothelial (bEnd3) cells subjected to oxygen-glucose deprivation.
  • Assessed cell viability, stroke outcomes, and hemorrhagic transformation in hyperglycemic mice after middle cerebral artery occlusion.
  • Employed Western blot to analyze apoptosis levels and the impact of O-GlcNAcylation modulation.

Main Results:

  • Upregulating O-GlcNAcylation with Thiamet-G attenuated injury in normal glucose but aggravated it in high glucose conditions.
  • In vivo, Thiamet-G worsened ischemic injury and hemorrhagic transformation, increasing apoptosis.
  • Inhibiting O-GlcNAcylation with 6-diazo-5-oxo-L-norleucine ameliorated cerebral injury in hyperglycemic mice.

Conclusions:

  • Protein O-GlcNAcylation plays a critical role in exacerbating cerebral ischemia injury during hyperglycemia.
  • Targeting O-GlcNAcylation presents a potential therapeutic strategy for ischemic stroke in hyperglycemic individuals, including those with AD.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
306
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
4.0K
Overview of Carbohydrate Metabolism01:19

Overview of Carbohydrate Metabolism

Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.2K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
3.6K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.3K
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
1.8K